MSHO Supports Cancer Clinical Research Efforts in Michigan
MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan's cancer patients.
With clinical trials being performed in Michigan at our four prestigious academic medical centers and six successful NCI Community Clinical Oncology Programs (CCOPs), cancer patients of Michigan should be able to consider a cancer clinical trial as a potential treatment option for their disease.
The Society has a long history of involvement in efforts to further Cancer Clinical Trial participation. MSHO was a co-convener of Michigan Cancer Consortium Clinical Trials Action Plan to double enrollment in Michigan Cancer Clinical Trials .
To view a current list of clinical trials each organization is participating in, please click their logo below.
The American Cancer Society Clinical Trials Matching Service is a free, confidential program that helps patients, their families and health care workers find clinical trials most appropriate to a patient's medical and personal situation.
The Michigan Cancer Consortium strongly supports facilitation of patient participation in cancer clinical trials. The Affordable Care Act REQUIRES that insurers cover the cost of routine care for a person in a clinical trial. This cover sheet was created for use in situations when elements of the clinical trial need clarification, such as when prior authorization is required.
PDQ (Physician Data Query) is NCI's comprehensive cancer database. It contains summaries on a wide range of cancer topics; a registry of 8000+ open and 19,000+ closed cancer clinical trials from around the world; and a directory of professionals who provide genetics services. PDQ also contains the NCI Dictionary of Cancer Terms, with definitions for 6000+ cancer and medical terms, and the NCI Drug Dictionary, which has information on 1200+ agents used in the treatment of cancer or cancer-related conditions.
Our Goal is to SIGNIFICANTLY IMPROVE LIVES through cancer clinical trials and translational research.
We TEST new ways to prevent and treat cancer.
We STUDY ways to improve the care cancer patients receive, and improve quality of life for survivors once initial treatment ends - relieving pain, promoting physical and mental health, and creating better end-of-life care.